Huntsman Ronald Kirk

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$116,207.40
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Huntsman Ronald Kirk

The largest purchase of all time was on 2021-09-21 and amounted to 5000 shares of Vivos Therapeutics, Inc. for $21,550.

Biography of Huntsman Ronald Kirk

No biography is available at this moment.

2023-06-20PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
14,000
0.059%
$0.53$7,420-59.28%
2023-06-16PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
15,000
0.065%
$0.54$8,050-59.28%
2023-06-15PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
21
<0.0001%
$0.50$11-59.28%
2023-06-14PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
10,000
0.0415%
$0.49$4,900-59.28%
2022-12-23PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
20,000
0.0911%
$0.50$10,000-26.62%
2022-05-31PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
8,000
0.0377%
$2.03$16,240-64.04%
2021-09-21PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
5,000
0.0241%
$4.31$21,550-50.23%
2021-08-17PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
5,000
0.0214%
$3.00$15,000-26%
2021-05-25PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
4,000
0.0198%
$5.38$21,520-43.81%
2020-12-23PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
1,000
0.0078%
$7.27$7,267-27.97%
2020-12-11PurchaseVivos Therapeutics, Inc.
VVOS
Chief Executive Officer
500
0.0037%
$8.50$4,250-40.16%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.